US 10034936
Method of inducing a cross-reactive HIV-1 immune response by administering a composition comprising the GBV-C E2 protein
granted A61KA61K2039/505A61K39/29
Quick answer
US patent 10034936 (Method of inducing a cross-reactive HIV-1 immune response by administering a composition comprising the GBV-C E2 protein) held by THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF VETERANS AFFAIRS expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF VETERANS AFFAIRS
- Grant date
- Tue Jul 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K2039/505, A61K39/29, A61P, A61P31/18